曲 媛,车轶群,沈 迪.N2~3期鼻咽癌EGFR、VEGF、EBER表达与放化疗敏感性的关系[J].中国肿瘤,2014,23(1):72-76.
N2~3期鼻咽癌EGFR、VEGF、EBER表达与放化疗敏感性的关系
Correlation of EGFR,VEGF and EBER With Chemoradiotherapy Sensitivity in Nasopharyngeal Carcinoma N2~3
投稿时间:2013-11-22  
DOI:10.11735/j.issn.1004-0242.2014.01.A017
中文关键词:  鼻咽癌  EBER  EGFR  VEGF
英文关键词:nasopharyngeal carcinoma  EBER  EGFR  VEGF
基金项目:北京希望马拉松专项 (LC2013B29)
作者单位
曲 媛 中国医学科学院肿瘤医院 
车轶群 中国医学科学院肿瘤医院 
沈 迪 中国医学科学院肿瘤医院 
摘要点击次数: 1913
全文下载次数: 853
中文摘要:
      摘 要:[目的] 探讨N2~3期鼻咽癌EGFR、VEGF、EBER表达与放化疗敏感性间的关系。[方法] 采用免疫组织化学方法研究143例经病理确诊的鼻咽癌患者组织EBER、EGFR和VEGF表达。定量PCR和酶联免疫吸附法(ELISA)检测92例N2~3期鼻咽癌患者血浆EB病毒游离DNA(EBV/DNA)、EGFR、VEGF的表达水平,并对92例N2~3期鼻咽癌随访2年。[结果] N2~3期鼻咽癌EBER、EGFR及VEGF表达阳性率分别为97.8%(90/92)、95.7%(88/92)和35.9% (33/92)。 EBER表达与远处转移、复发及临床缓解相关,VEGF和EGFR表达强度与远处转移均呈正相关。N2~3期鼻咽癌患者血浆EBV/DNA、EGFR、VEGF治疗前与同步放化疗后比较差异均有统计学意义(P均<0.05)。血浆中EGFR和VEGF表达水平与远处转移相关。[结论] 血浆和组织中EGFR和VEGF表达水平均可能与鼻咽癌远处转移相关。
英文摘要:
      Abstract:[Purpose] To investigate the correlation of EGFR,VEGF,EBER expression with chemoradiotherapy sensitivity in nasopharyngeal carcinoma(NPC) N2~3. [Methods] The expression of EGFR,VEGF and EBER protein was examined in 143 cases with NPC pathologically proven. Plasma VEGF & EGFR were detected by enzyme-linked immunosorbent assay(ELISA) and EB virus free DNA(EBV/DNA) was detected by real-time PCR in 92 patients with NPC N2~3 and followed-up 2 years.[Results] The positive rate of EBER,EGFR and VEGF was 97.8%(90/92),95.7%(88/92) and 35.9%(33/92) respectively in NPC cancer tissue. The level of EBER was correlated to distant metastasis,reurrence and clinical-remission(P<0.05). There was a positive correlation between VEGF,EGFR expression and distant metastasis. The plasma VEGF,EGFR and EBV/DNA levels of pretreatment were higher than those of post-treatment. The plasma EGFR and VEGF were correlated to distant metastasis.[Conclusion] Expression of VEGF and EGFR in tissuses and plasma might be an early warming for distant metastasis.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器